Clinical Trials Are Going Global: Is Your Site Selection Strategy Ready?
The pharmaceutical industry has undergone a seismic shift over the past 25 years. Clinical trials have fundamentally transformed from a predominantly U.S.-centered activity to a truly global enterprise. The implications for how you plan and execute trials are profound.
The Numbers Tell a Dramatic Story
Here’s a statistic that should reshape how you think about clinical trial geography: In 2000, only 40% of trials included at least one site outside the United States. By 2024, that number had nearly doubled to 79%—representing a dramatic 39-percentage-point expansion.
This isn’t just growth. It’s a complete restructuring of where pharmaceutical research happens. This transformation represents the emergence of a mature, global clinical trial ecosystem where sponsors have genuine choices about where to conduct research, and where the right choice can make or break your program’s success.
Want to see the complete data behind this shift? Download our full analysis.
New Global Powerhouses Are Emerging
The globalization hasn’t created a random scatter of trial sites. Instead, clear regional hubs have emerged, each with distinct advantages and growth trajectories.
Our comprehensive analysis reveals how different regions have positioned themselves strategically—from regulatory reforms that streamline multi-country approvals to infrastructure investments that dramatically accelerate enrollment timelines. Some markets have emerged as leaders in specific trial phases, while others have developed expertise across particular therapeutic areas.
The data shows remarkable shifts in where trials are conducted, with several countries experiencing explosive growth that’s reshaping the competitive landscape for site selection.
It’s Not Just About Geography Anymore
This transformation extends across every type of clinical research. Our analysis of 25 years of trial data reveals that the shift to international distribution is happening across all phases, from Phase 1 through Phase 4, and across all major therapeutic areas.
What does this mean for your clinical development strategy? You can no longer assume your indication will naturally lead you to specific countries. The landscape has fundamentally changed, and success requires understanding exactly where the opportunities are for your specific trial needs.
Get the detailed breakdown by phase and therapeutic area.
The New Reality: Complexity Requires Better Intelligence
With the majority of trials now conducted internationally, every clinical team faces critical questions:
- Which countries have the strongest site infrastructure for my indication?
- Where have similar trials succeeded or failed?
- Which investigators have the right expertise and access to my target patients?
- How do I benchmark site performance across regions?
Perhaps most challenging is the pace of change itself. What was true about global trial patterns even five years ago no longer reflects today’s reality. Success in this dynamic landscape demands data that isn’t just comprehensive, but current and actionable.
The Strategic Imperative
Clinical trials have fundamentally shifted to a global model, and there’s no going back. For clinical development teams, this creates both unprecedented opportunities and new complexities that demand sophisticated global intelligence.
The companies that succeed will be those that can identify, evaluate, and select the right sites across dozens of countries—turning geographic diversity from a challenge into a competitive advantage.
Ready to see the complete picture? Our comprehensive white paper, “The International Shift in Clinical Trials: Why Global Data Is More Critical Than Ever,” provides:
- Detailed data visualizations showing 25 years of geographic trial trends
- Country analysis to understand the emerging and leading countries in clinical research
- Phase and therapeutic area breakdowns revealing where opportunities exist
- Strategic recommendations for navigating the new global landscape
Download the Full White Paper.
Learn more about H1’s global clinical trial intelligence platform and how we’re helping teams succeed in the new global trial environment at h1.co/request-demo
